Regulation of D2 dopamine receptors by amiloride and amiloride analogs

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1295-1308

  Hoare, S R J ^a   Strange, P G ^a  

^a The University   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMILORIDE DERIVATIVE; DOPAMINE 2 RECEPTOR; SPIPERONE; 5 (N ISOBUTYL N METHYL)AMILORIDE; 5-(N-METHYL-N-ISOBUTYL)AMILORIDE; DIURETIC AGENT; DRUG DERIVATIVE; GUANOSINE TRIPHOSPHATE; MAGNESIUM CHLORIDE; SODIUM PROTON EXCHANGE PROTEIN; TRITIUM;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING KINETICS; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BINDING COMPETITION; BINDING SITE; DRUG ANTAGONISM; KINETICS; METABOLISM; RADIOASSAY;

AMILORIDE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; DIURETICS; GUANOSINE TRIPHOSPHATE; KINETICS; MAGNESIUM CHLORIDE; RADIOLIGAND ASSAY; RATS; RECEPTORS, DOPAMINE D2; SODIUM-HYDROGEN ANTIPORTER; SPIPERONE; TRITIUM;

EID: 0029661853     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tucek, S., and J. Proska. Allosteric modulation of muscarinic acetylcholine receptors. Trends. Pharmacol. Sci. 16:205-212 (1995).
2. Stockton, J. M., N. J. M. Birdsall, A. S. V. Burgen, and E. C. Hulme. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23:551-557 (1983).
3. Ellis, J., M. Seidenberg, and M. R. Brann. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol. Pharmacol. 44:583-588 (1993).
4. Matsui, H., S. Lazareno, and N. J. M. Birdsall. Probing of the location of the allosteric site on ml muscarinic receptors by site-directed mutagenesis. Mol. Pharmacol. 47:88-98 (1995).
5. Lee, N. H., and E. E. El-Fakahany. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 258:468-479 (1991).
6. Ellis, J., J. Huyler, and M. R. Brann. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem. Pharmacol. 42:1927-1932 (1991).
7. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol. Pharmacol. 38:939-949 (1990).
8. 1 receptor binding by 2-amino-3-benzoylthiophenes. Mol. Pharmacol. 38:950-958 (1990).
9. Mudumbi, R. V., S. C. Montamat, R. F. Bruns, and R. E. Vestal. Cardiac functional responses to adenosine by PD 81,723, an allosteric enhancer of the adenosine A, receptor. Am. J. Physiol. 264:H1017-H1022 (1993).
10. Birdsall, N. J. M., E. C. Hulme, W. Kromer, B. S. Peck, J. M. Stockton, and M. J. Zigmond. Two drug binding sites on muscarinic receptors, in New Concepts in Alzheimer's Disease (M. Briley, A. Kato, and M. Weber, eds.). Macmillan, London (1986).
11. Ehlert, F. J. Estimation of the affinities of allosteric ligands using radio-ligand binding and pharmacological null methods. Mol. Pharmacol. 33: 187-194 (1988).
12. Lazareno, S., and N. J. M. Birdsall. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48:362-378 (1995).
13. 2 receptors by sodium and pH. Mol. Pharmacol. 39:570-578 (1991).
14. + exchange. J. Biol. Chem. 262:12387-12392 (1987).
15. Kleyman, T. R., and E. J. Cragoe, Jr. Cation transport probes: the amiloride series. Methods Enzymol. 191:739-755 (1990).
16. 2-adrenergic receptors by sodium. J. Biol. Chem. 265:21590-21595 (1990).
17. 2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol. 39:733-739 (1991).
18. 2-adrenergic receptors. Mol. Pharmacol. 32:53-58 (1987).
19. 2 dopamine receptor. J. Neurochem. 60:372-375 (1993).
20. 3H]spiperone depend on tissue concentration: analysis and examples. J. Neurochem. 43:221-235 (1984).
21. Arunlakshana, O., and H. O. Schild. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14:48-58 (1959).
22. + exchange system. Mol. Pharmacol. 25:131-136 (1984).
23. Garcia, M. L., F. V. King, J. L. Shevell, R. S. Slaughter, G. Suarez-Kurtz, R. J. Winquist, and G. J. Kaczorowski. Amiloride analogues inhibit L-type calcium channels and display calcium entry blocker activity. J. Biol. Chem. 265:3763-3771 (1990).
24. + exchange. Mol. Pharmacol. 42:175-179 (1992).
25. + exchange assessed by quantification of extracellular acidification. J. Biol. Chem. 267:25748-25753 (1992).
26. 2 dopamine receptors. Mol. Pharmacol. 45:51-60 (1994).
27. Chio, C. L., R. F. Drong, D. T. Riley, G. S. Gill, J. L. Slightom, and R. M. Huff. D4 dopamine receptor-mediated signalling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem. 269:11813-11819 (1994).
28. 3H]spiperone. Biochem. Soc. Trans. 24:53S (1996).
29. 1-Subunit of the dihydropyridine receptor from skeletal muscle. Nature (Land.) 340:233-236 (1989).
30. Henis, Y. I., Y. Kloog, and M. Sokolovsky. Allosteric interactions of muscarinic receptors and their regulation by other membrane proteins, in The Muscarinic Receptors (J. H. Brown, ed.). Humana Press, Totowa, NJ (1989).
31. Ellis, J., and M. Seidenberg. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol. Pharmacol. 42:638-641 (1992).
32. Kenakin, T. Pharmacologic Analysis of Drug-Receptor Interaction. 2nd ed. Raven Press, New York, 315-318 (1993).
33. Hulme, E. C., and N. J. M. Birdsall. Strategy and tactics in receptor binding studies, in Receptor-Ligand Interactions: A Practical Approach (E. C. Hulme, ed.). Oxford University Press, New York (1992).
34. DeLean, A., B. F. Kilpatrick, and M. G. Caron. Dopamine receptors of the porcine anterior pituitary gland: evidence for two affinity states discriminated by both agonists and antagonists. Mol. Pharmacol. 22;290-297 (1982).
35. 2 dopamine receptors by magnesium and sodium ions. J. Neurochem. 45:1842-1849 (1985).
36. 2 dopamine receptors from the high- to low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J. Neurochem. 44:1925-1935 (1985).
37. 2 dopamine receptor of the anterior pituitary gland. Mol. Pharmacol, 26:214-227 (1984).
38. 2 receptors: kinetic evidence for antagonist-induced formation of ternary complex. Mol. Pharmacol. 33:402-413 (1988).
39. Sato, M., R. Kataoko, J. Dingus, M. Wilcox, J. D. Hildebrandt, and S. M. Lanier, Factors determining specificity of signal transduction by G-protein-coupled receptors. J. Biol. Chem. 270:15269-15276 (1995).
40. Potter, L. T., C. A. Ferrendelli, H. E. Hanchett, M. A. Hollifield, and M. V. Lorenzi. Tetrahydroaminoachridine and other allosteric antagonists of hippocampal M1 muscarinic receptors. Mol. Pharmacol. 35:652-660 (1989).